Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Autonomix Medical (NASDAQ: AMIX) announced the release of a new CEO Corner segment on their website. The segment features CEO Brad Hauser sharing insights from the 43rd Annual J.P. Morgan Healthcare Conference and reviewing recent industry news. Autonomix is a medical device company developing technologies for diagnosing and treating nervous system diseases.
Autonomix Medical (NASDAQ: AMIX) ha annunciato il lancio di un nuovo segmento CEO Corner sul proprio sito web. Il segmento presenta il CEO Brad Hauser che condivide informazioni dalla 43esima Conferenza Annuale J.P. Morgan Healthcare e analizza le recenti novità del settore. Autonomix è un'azienda di dispositivi medici che sviluppa tecnologie per diagnosticare e trattare malattie del sistema nervoso.
Autonomix Medical (NASDAQ: AMIX) anunció el lanzamiento de un nuevo segmento CEO Corner en su sitio web. El segmento presenta al CEO Brad Hauser compartiendo perspectivas de la 43ª Conferencia Anual J.P. Morgan Healthcare y revisando las noticias recientes de la industria. Autonomix es una empresa de dispositivos médicos que desarrolla tecnologías para diagnosticar y tratar enfermedades del sistema nervioso.
Autonomix Medical (NASDAQ: AMIX)가 웹사이트에 새로운 CEO Corner 세그먼트를 출시했다고 발표했습니다. 이 세그먼트에는 CEO 브래드 하우저가 43번째 연례 J.P. 모건 헬스케어 컨퍼런스에서의 통찰력을 공유하고 최근 산업 뉴스를 검토하는 내용이 포함되어 있습니다. Autonomix는 신경계 질환을 진단하고 치료하기 위한 기술을 개발하는 의료 기기 회사입니다.
Autonomix Medical (NASDAQ: AMIX) a annoncé le lancement d'un nouveau segment CEO Corner sur son site web. Ce segment présente le PDG Brad Hauser partageant ses réflexions lors de la 43ème Conférence Annuelle J.P. Morgan Healthcare et examinant les récentes nouvelles de l'industrie. Autonomix est une entreprise de dispositifs médicaux développant des technologies pour diagnostiquer et traiter les maladies du système nerveux.
Autonomix Medical (NASDAQ: AMIX) hat die Veröffentlichung eines neuen CEO Corner Segments auf seiner Website angekündigt. In dem Segment teilt CEO Brad Hauser Einblicke von der 43. jährlichen J.P. Morgan Healthcare Conference und lässt die aktuellen Branchennachrichten Revue passieren. Autonomix ist ein Medizintechnikunternehmen, das Technologien zur Diagnose und Behandlung von Nervensystemerkrankungen entwickelt.
- None.
- None.
THE WOODLANDS, TX, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the next CEO Corner segment has been published on the Company’s website. For the segment, Brad Hauser, CEO of Autonomix, shared feedback from the recently held 43rd Annual J.P. Morgan Healthcare Conference and recapped some of the latest relevant industry news.
The CEO Corner segment is now available here.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com
FAQ
What did Autonomix Medical (AMIX) announce in their January 24, 2025 press release?
What was discussed in Autonomix Medical's (AMIX) latest CEO Corner segment?
What is the main focus of Autonomix Medical (AMIX) as a company?
When did Autonomix Medical (AMIX) attend the J.P. Morgan Healthcare Conference?
